Optima Pharma

Optima Pharma, headquartered in Germany, operates in the Chemical and fertilizer minerals, salt and other mining and quarrying products n.e.c. industry.

In 2020, Optima Pharma reported total emissions of approximately 372,000 kg CO2e. This included Scope 1 emissions of 11,160 kg CO2e, Scope 2 emissions of 11,160 kg CO2e, and Scope 3 emissions of 349,680 kg CO2e. The company also reported emissions data for 2014, with total emissions of approximately 383,000 kg CO2e, comprising 22,980 kg CO2e for Scope 1, 15,320 kg CO2e for Scope 2, and 344,700 kg CO2e for Scope 3. No emissions data was disclosed for 2021.

Optima Pharma has set ambitious climate commitments. The company aims to reduce its Scope 1 and 2 carbon footprint from its own operations by at least 50% by 2030, using 2021 as a baseline, and to achieve net-zero emissions by 2050. Additionally, Optima Pharma has a near-term absolute reduction target to decrease its Scope 1 emissions by an additional 25% by 2030, with 2022 as the base year, and a similar 25% reduction target for Scope 2 emissions by 2030, also against a 2022 baseline. These reduction efforts are supported by measures such as sourcing green electricity since 2009 and increasing energy and resource efficiency. The company also plans to continue compensating 100% of non-avoidable Scope 1 and Scope 2 emissions from 2023 to 2050. These targets and commitments are cascaded from its parent company, OPTIMA packaging group GmbH.